Robert W. Carlson, MD, CEO of the National Comprehensive Cancer Network (NCCN), discussed calculating value in cancer care and the dimensions of NCCN's value assessment framework, Evidence Blocks.
Robert W. Carlson, MD, CEO of the National Comprehensive Cancer Network (NCCN), discussed calculating value in cancer care and the dimensions of NCCN's value assessment framework, Evidence Blocks.
Transcript (slightly modified)
Why do we need value calculators and the value discussion in oncology today?
Value in oncology care today is a very important topic because the effectiveness of therapies but also because of the cost—both to society and to the individual patient—of the individual therapies. And so it's a circumstance where it's important to know what the consumer, what the healthcare system is getting in return for the dollar cost that is being spent on cancer care. It's very complicated and providing transparent information either by text, tables, or computer-based calculators is very important.
What are the cornerstones of NCCN's Evidence Blocks?
The NCCN Evidence Blocks are based upon 5 different dimensions of data or decision making. The first is the dimension of efficacy: how effective is the therapy? The second is safety: how safe is it to receive the therapy, what kind of difficulties or toxicities would the patient experience with the therapy? The third is that of data quality and quantity that supports the recommendation. The fourth is the consistency of the information that supports the recommendation. And the fifth is that of affordability and how affordable is the therapy to the medical system or society.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More